Unique Russian development will be sold in the USA
The Russian company Semiotic has started exporting products to the USA
The innovative product of Russian developers has no analogues. The glycochip contains the world's largest library of carbohydrate glycans, which has been created for 30 years. Already, up to 600 carbohydrate glycans can be placed on the chip and with their help extract information about hundreds of pathologies at the same time.
The detection of glycan-specific antibodies in the blood opens up new opportunities for the diagnosis of a wide range of infectious, autoimmune and oncological diseases. Mapping the specificity of bacterial and viral lectins, as well as bacteriophage glycanases, is a key stage in the development of new generation antimicrobial drugs, alternative to classical antibiotics.
A microchip is a thin plate made of plastic, which is significantly superior to traditional glass analogues. Plastic is good in combination with the chemistry of attaching antigens to the surface, which reduces the number of stages of the process from ten to two.
The concept of a unique microchip originated and was developed at the Institute of Bioorganic Chemistry named after M.M.Shemyakin and Yu.A.Ovchinnikov of the Russian Academy of Sciences by the team of the Carbohydrate Laboratory together with New York University.
In the future, the use of these microchips will improve the quality and speed of blood transfusion stations, plasma processing plants, as well as clinics, laboratories, medical diagnostic centers and other medical organizations that conduct blood tests to detect malignant tumors and pathogens.
Among the priorities of the Semiotic company is the expansion of the customer base in Russia. Negotiations are already underway with the N.N.Blokhin Russian Cancer Research Center, the P.A.Herzen Moscow Cancer Research Institute, and the Academician V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation.
"Throughout the entire period since Biofund joined the Semiotic team, we have felt interest in the company's technology from foreign scientific and business partners," said Egor Beketov, CEO of the RVC Biofund. "The deal with GlycoTech is for us the first confident step we are taking in promoting glycochip on international markets."
Semiotic Company is an innovative high–tech company whose field of activity is the development and production of microchips for blood analysis. The scientific director of the company is a leading Russian expert on this subject – Nikolay Vladimirovich Bovin, Doctor of Chemical Sciences, Professor, Head of the Carbohydrate Laboratory of the M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences.
GlycoTech Corporation (USA) was founded in 1991 and is a key supplier of reagents for glycobiological research in the USA. The company actively conducts its own research in the field of finding glycotherapeutics, acts as a partner for pharmaceutical, biotech companies and research centers in the United States.
Portal "Eternal youth" http://vechnayamolodost.ru27.05.2015